Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 535-537

  Ho, Pak Leung ^a   Sin, Wai Ching ^b   Chan, Jasper Fuk Woo ^a   Cheng, VincentChi Chung ^a   Chan, Kwok Hung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFTRIAXONE; OSELTAMIVIR; VIRUS SIALIDASE; ZANAMIVIR; ANTIVIRUS AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; AVIAN INFLUENZA VIRUS; CASE REPORT; CHINA; COUGHING; DISEASE COURSE; DRUG RESPONSE; ENDOTRACHEAL INTUBATION; EXTRACORPOREAL OXYGENATION; FEMALE; FEVER; HONG KONG; HUMAN; INFLUENZA A; INFLUENZA VIRUS A; INFLUENZA VIRUS A H7N9; LUNG INFILTRATE; MALAISE; PALLIATIVE THERAPY; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THORAX RADIOGRAPHY; VIRAL CLEARANCE; VIRUS LOAD; VITILIGO; BLOOD; INFLUENZA; PNEUMONIA, VIRAL; RESPIRATION DISORDERS; TIME; TREATMENT OUTCOME; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; FEMALE; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; PNEUMONIA, VIRAL; RESPIRATION DISORDERS; TIME FACTORS; TREATMENT OUTCOME; ZANAMIVIR;

EID: 84897579247     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00006414     Document Type: Article

References (7)

1. To KK, Chan JF, Chen H, et al. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 2013; 13: 809-821.
2. Chen Y, Liang W, Yang S, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013; 381: 1916-1925.
3. Chan JF, To KK, Tse H, et al. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol 2013; 21: 544-555.
4. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013; 381: 2273-2279.
5. Wang W, Ren P, Mardi S, et al. Design of multiplexed detection assays for identification of avian influenza a virus subtypes pathogenic to humans by SmartCycler real-time reverse transcription-PCR. J Clin Microbiol 2009; 47: 86-92.
6. Centers for Disease Control and Prevention. Interim guidance on the use of antiviral agents for treatment of human infections with avian influenza A (H7N9) virus. www.cdc.gov/flu/avianflu/h7n9-antiviral-treatment.htm Date last accessed: January 9, 2014. Date last updated: September 30, 2013.
7. World Health Organization. Avian influenza A(H7N9) virus. www.who.int/influenza/human-animal-interface/influenza-h7n9/en/ Date last accessed: January 9, 2014. Date last updated: May 31, 2013.